Healthcare organizations seek solutions in national Measure Up, Pressure Down campaign

Article

Members of the American Medical Group Association (AMGA) are participating in Measure Up, Pressure Down, a nationwide healthcare initiative aimed at preventing, detecting, and controlling high blood pressure.

Alexandria, VA-More than 120 members of the American Medical Group Association (AMGA) have joined together to participate in Measure Up, Pressure Down, a new nationwide healthcare initiative aimed at preventing, detecting, and controlling high blood pressure.

Measure Up, Pressure Down is a 3-year campaign that targets having 80% of hypertensive patients in control of their condition by 2016. The program is spearheaded by the American Medical Group Foundation (AMGF), AMGA’s nonprofit education and research arm. Participating organizations include the U.S. Department of Health and Human Services, Mayo Clinic, Cleveland Clinic, Kaiser Permanente, and Geisinger Health System.

“By challenging medical groups and health providers to raise the bar on high blood pressure care and control, we can make a dramatic difference in the health and wellbeing of our population,” said Donald W. Fisher, PhD, CAE, president and chief executive officer of AMGA and secretary of the board of AMGF. “AMGA member medical groups are well positioned to successfully lead this critically important national effort.”

The campaign is sponsored by Novartis Pharmaceuticals Corp. and Daiichi Sankyo Inc. For more information, visit www.MeasureUpPressureDown.com.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
© 2025 MJH Life Sciences

All rights reserved.